# A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma

> **NCT05888844** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Incyte Corporation** · enrollment: 63 (actual)

## Conditions studied

- Cutaneous Squamous Cell Carcinoma

## Interventions

- **DRUG:** INCB099280

## Key facts

- **NCT ID:** NCT05888844
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-09
- **Primary completion:** 2026-09-28
- **Final completion:** 2026-09-28
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05888844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05888844, "A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05888844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*